Measures against COVID-19 pandemic – a single tertiary center experience

İlgen, Orkun; Saatli, Bahadır; Timur, Hikmet Tunç; Kula, Hakan; Kandemir, Selim; Kurt, Sefa; Çağlıyan, Erkan

doi:10.1080/01443615.2021.2021506

Cited by 2 publications

(2 citation statements)

References 35 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The COVID-19 pandemic, caused by the novel coronavirus SARS-CoV-2, has had a profound impact on global health, economies, and societies worldwide [ 19 , 20 ]. Due to the high transmissibility of the virus, preventive measures such as wearing masks, practicing physical distancing, and frequent hand hygiene played a crucial role in mitigating transmission [ 21 , 22 ]. As regards dermatological clinical practice, teledermatology emerged as a valuable tool in providing remote dermatological care during the pandemic.…”

Section: Introductionmentioning

confidence: 99%

New Onset and Exacerbation of Psoriasis Following COVID-19 Vaccination: A Review of the Current Knowledge

et al. 2023

View full text Add to dashboard Cite

COVID-19 vaccination was the main measure to overcome the pandemic. As with other drugs and vaccines, mild to moderate adverse events have been reported following vaccination. In addition, several cutaneous reactions have been described. In particular, there are several reports investigating de novo psoriasis or the exacerbation of psoriasis following COVID-19 vaccination. However, data on the possible pathogenetic mechanisms as well as comprehensive manuscripts on the topic are scant. Thus, the aim of our manuscript was to perform a review of the current literature on post-COVID-19 vaccination exacerbations and new-onset psoriasis in order to offer a wide perspective on this area and to point out possible pathogenetic mechanisms. Research on the current literature was performed following PRISMA guidelines. In total, 49 studies involving 134 patients developing new-onset psoriasis (n = 27, 20.1%) or psoriasis exacerbation (n = 107, 79.9%) were collected. Although cases of de novo psoriasis or a worsening of psoriasis have been reported following vaccination, all of the cases have been successfully treated while overall benefit–risk profile of COVID-19 vaccination does not justify vaccine hesitancy due to the risk of psoriasis being developed or worsening. Certainly, further studies are needed to identify possible pathogenetic mechanisms in order to identify “at-risk” patients. Finally, vaccination should not be discouraged.

show abstract

Section: Introductionmentioning

confidence: 99%

New Onset and Exacerbation of Psoriasis Following COVID-19 Vaccination: A Review of the Current Knowledge

et al. 2023

View full text Add to dashboard Cite

show abstract

“…Due to the high transmissibility of SARS-CoV-2 preventive measures like wearing masks, physical distancing was necessary, and in this context, COVID-19 vaccination was the main measure to overcome the pandemic. 97 The European Medicines Agency (EMA) approved four vaccines based on two different mechanism of action: mRNA vaccines (Pfizer/BioNTech; BNT162b2 and Moderna; mRNA-1273) and viral vector-based vaccines (AstraZeneca; AZD1222 and Johnson & Johnson; Ad26.COV2.S). 98 Several cutaneous adverse reactions have been described in patients receiving COVID-19 vaccination, and in particular cases of psoriasis occurring de novo or psoriasis flare-ups have been reported.…”

Section: Resultsmentioning

confidence: 99%

Risk Factors for Psoriasis Flares: A Narrative Review

Potestio,

Lauletta,

Tommasino

et al. 2024

PTT

View full text Add to dashboard Cite

Psoriasis is a chronic inflammatory cutaneous disease with multifactorial pathogenesis involving both genetic and environmental factors as well as the innate and acquired immune response. Several triggering factors may exacerbate or worsen the disease. In this context, we performed a review manuscript with the aim of investigating current literature on psoriasis risk factors, also showing possible mechanisms by which they act on psoriasis. Globally, risk factors can be divided in classic risk factors (eg, mechanical stress, infections and dysbiosis of the skin, common drugs, environment and pollution, lifestyle, psychological stress, hormonal and metabolic alterations) which have long been known to be responsible for worsening and/or reoccurrence of psoriatic manifestations, and emerging risk factors (eg, biological drugs, immunotherapy for oncologic disease, Covid-19, and vaccines) defined as those newly identified risk factors. Accurate patient information and monitoring of risk factors as well as planned follow-ups may help to prevent and treat the worsening of psoriasis and consequently improve the quality of life of psoriatic patients.

show abstract

Measures against COVID-19 pandemic – a single tertiary center experience

Cited by 2 publications

References 35 publications

New Onset and Exacerbation of Psoriasis Following COVID-19 Vaccination: A Review of the Current Knowledge

New Onset and Exacerbation of Psoriasis Following COVID-19 Vaccination: A Review of the Current Knowledge

Risk Factors for Psoriasis Flares: A Narrative Review

Contact Info

Product

Resources

About